These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12817525)

  • 1. Pharmacokinetics and pharmacodynamics of intrathecal ziconotide in chronic pain patients.
    Wermeling D; Drass M; Ellis D; Mayo M; McGuire D; O'Connell D; Hale V; Chao S
    J Clin Pharmacol; 2003 Jun; 43(6):624-36. PubMed ID: 12817525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic analysis of ziconotide (SNX-111), an intrathecal N-type calcium channel blocking analgesic, delivered by bolus and infusion in the dog.
    Yaksh TL; de Kater A; Dean R; Best BM; Miljanich GP
    Neuromodulation; 2012; 15(6):508-19; discussion 519. PubMed ID: 22748108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.
    Staats PS; Yearwood T; Charapata SG; Presley RW; Wallace MS; Byas-Smith M; Fisher R; Bryce DA; Mangieri EA; Luther RR; Mayo M; McGuire D; Ellis D
    JAMA; 2004 Jan; 291(1):63-70. PubMed ID: 14709577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of ziconotide in intrathecal pain management for severe chronic pain patients in the UK.
    Dewilde S; Verdian L; Maclaine GD
    Curr Med Res Opin; 2009 Aug; 25(8):2007-19. PubMed ID: 19563256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain.
    Webster LR; Fakata KL; Charapata S; Fisher R; MineHart M
    Pain Med; 2008 Apr; 9(3):282-90. PubMed ID: 18366508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain.
    Atanassoff PG; Hartmannsgruber MW; Thrasher J; Wermeling D; Longton W; Gaeta R; Singh T; Mayo M; McGuire D; Luther RR
    Reg Anesth Pain Med; 2000; 25(3):274-8. PubMed ID: 10834782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term intrathecal ziconotide for chronic pain: an open-label study.
    Webster LR; Fisher R; Charapata S; Wallace MS
    J Pain Symptom Manage; 2009 Mar; 37(3):363-72. PubMed ID: 18715748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II, open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of ziconotide in patients receiving intrathecal morphine for severe chronic pain.
    Wallace MS; Kosek PS; Staats P; Fisher R; Schultz DM; Leong M
    Pain Med; 2008 Apr; 9(3):271-81. PubMed ID: 18366507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review.
    Klotz U
    Int J Clin Pharmacol Ther; 2006 Oct; 44(10):478-83. PubMed ID: 17063978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal ziconotide and baclofen provide pain relief in seven patients with neuropathic pain and spasticity: case reports.
    Saulino M; Burton AW; Danyo DA; Frost S; Glanzer J; Solanki DR
    Eur J Phys Rehabil Med; 2009 Mar; 45(1):61-7. PubMed ID: 19156022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal ziconotide and opioid combination therapy for noncancer pain: an observational study.
    Deer TR; Kim C; Bowman R; Tolentino D; Stewart C; Tolentino W
    Pain Physician; 2009; 12(4):E291-6. PubMed ID: 19668287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ziconotide.
    Lyseng-Williamson KA; Perry C
    CNS Drugs; 2006; 20(4):331-8; discussion 339-41. PubMed ID: 16599651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain.
    Rauck RL; Wallace MS; Leong MS; Minehart M; Webster LR; Charapata SG; Abraham JE; Buffington DE; Ellis D; Kartzinel R;
    J Pain Symptom Manage; 2006 May; 31(5):393-406. PubMed ID: 16716870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain.
    Wermeling DP
    Pharmacotherapy; 2005 Aug; 25(8):1084-94. PubMed ID: 16207099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice.
    Alicino I; Giglio M; Manca F; Bruno F; Puntillo F
    Pain; 2012 Jan; 153(1):245-249. PubMed ID: 22082570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal ziconotide: a review of its use in patients with chronic pain refractory to other systemic or intrathecal analgesics.
    Sanford M
    CNS Drugs; 2013 Nov; 27(11):989-1002. PubMed ID: 23999971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bolus intrathecal injection of ziconotide (Prialt®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study.
    Mohammed SI; Eldabe S; Simpson KH; Brookes M; Madzinga G; Gulve A; Baranidharan G; Radford H; Crowther T; Buchser E; Perruchoud C; Batterham AM
    Neuromodulation; 2013; 16(6):576-81; discussion 582. PubMed ID: 23205907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of ziconotide to cerebrospinal fluid via intranasal pathway for the treatment of chronic pain.
    Manda P; Kushwaha AS; Kundu S; Shivakumar HN; Jo SB; Murthy SN
    J Control Release; 2016 Feb; 224():69-76. PubMed ID: 26732557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial.
    Wallace MS; Rauck R; Fisher R; Charapata SG; Ellis D; Dissanayake S;
    Anesth Analg; 2008 Feb; 106(2):628-37, table of contents. PubMed ID: 18227325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.